Cantitate/Preț
Produs

Management of Thyroid Cancer: Special Considerations (Head and Neck Cancer Clinics)

Editat de K. Alok Pathak, Richard W. Nason, Janice L. Pasieka
Notă GoodReads:
en Limba Engleză Hardback – 30 Jul 2015
Thyroid cancer is the most common malignant endocrine tumor and is the seventh most common cancer seen in throughout out the world. The incidence of thyroid cancer has been increasing more rapidly than any other cancer in many of the cancer registries from different parts of the world.
Although the majority of thyroid cancers have an indolent biological behaviour, different histological types have a diverse clinical behaviour. Well-differentiated thyroid cancers have an excellent survival, whereas poorly differentiated and anaplastic thyroid cancers have a very poor outcome. This volume of Head and Neck Cancer Clinics addresses advances, controversies and state-of-the-art treatment recommendations of various types of thyroid cancers.
Citește tot Restrânge
Toate formatele și edițiile
Toate formatele și edițiile Preț Express
Paperback (1) 58237 lei  Economic 7-9 săpt.
  Springer India – 23 Oct 2016 58237 lei  Economic 7-9 săpt.
Hardback (1) 40193 lei  Economic 7-9 săpt. +8775 lei  13-20 zile
  Springer India – 30 Jul 2015 40193 lei  Economic 7-9 săpt. +8775 lei  13-20 zile

Din seria Head and Neck Cancer Clinics

Preț: 40193 lei

Preț vechi: 42758 lei
-6%

Puncte Express: 603

Preț estimativ în valută:
7781 9258$ 6628£

Carte tipărită la comandă

Livrare economică 18 septembrie-02 octombrie
Livrare express 13-20 august pentru 9774 lei

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9788132224334
ISBN-10: 8132224337
Pagini: 185
Ilustrații: 3 schwarz-weiße und 11 farbige Abbildungen, Bibliographie
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.38 kg
Ediția: 1st ed. 2015
Editura: Springer India
Colecția Springer
Seria Head and Neck Cancer Clinics

Locul publicării: New Delhi, India

Public țintă

Professional/practitioner

Cuprins

​ Molecular risk stratification of well-differentiated thyroid cancer.- The significance of cervical lymph nodes in well-differentiated thyroid cancer.- Management of the central compartment in well-differentiated thyroid carcinoma.- Management of the lateral neck in well-differentiated thyroid cancer.- The management of recurrent/persistent well-differentiated thyroid cancer in the central compartment.- Management of distant metastases in differentiated thyroid cancer.- Risk-adjusted strategies in post-treatment surveillance of well-differentiated thyroid carcinoma.- Medullary thyroid cancer.- Anaplastic thyroid cancer: Current concepts.- External beam radiotherapy for thyroid cancer.- Targeted therapies in thyroid cancer

Notă biografică


 K. Alok Pathak
Professor of Surgery
University of Manitoba
Head and Neck Surgical Oncology
Cancer Care Manitoba, Canada

Richard W. Nason
Professor
Head and Neck Surgical Oncology
Cancer Care Manitoba
Winnipeg, Canada 
Janice L. Pasieka
Clinical Professor of Surgery and Oncology
Section of General Surgery and Surgical Oncology
University of Calgary, Canada

Textul de pe ultima copertă

Thyroid cancer is the most common malignant endocrine tumour. The incidence of thyroid cancer has been increasing more rapidly than any other cancer in many of the cancer registries from different parts of the world.
 Although the majority of thyroid cancers have an indolent biological behavior, different histological types have a diverse clinical behavior. Well-differentiated thyroid cancers have an excellent survival, whereas poorly differentiated and anaplastic thyroid cancers have a very poor outcome. This volume of Head and Neck Cancer Clinics addresses advances, controversies and state-of-the-art treatment recommendations of various types of thyroid cancers.
 
 

Caracteristici

Encompasses the molecular risk stratification
Management of regional and distant metastatic thyroid cancer
Salvage of central compartment recurrence, role of external beam radiation therapy and post-treatment surveillance of thyroid cancer
Management of medullary and anaplastic thyroid cancer and the evolving role of targeted therapy in thyroid cancer have been discussed in separate chapters
Each chapter is followed by an editorial commentary